Here we demonstrate that Ketorolac being a potent secretagogue causing Par-4 induction leads to modulation of Rac-1/Cdc42 thereby inhibiting proliferation, hypoxia, metastasis and apoptosis in RCC. The gene discussed is CDC42; the disease is renal cell carcinoma.